Adjunctive antioxidants for schizophrenia vs placeboGeneral functioning ‐ short term GAS · patients with schizophrenia1 finding from 1 reviewAntioxidant treatments for schizophrenia 2016 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 52 participantsLow